OKLAHOMA CITY, OK -- 12/04/08 --
On December 2, 2008, a class action
lawsuit was filed in the United States District Court for the Eastern
District of Missouri against KV Pharmaceutical Company (NYSE: KV-A) (NYSE: KV-B). The complaint alleges violations of federal securities laws,
Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule
10b-5, including allegations of issuing a series of material
misrepresentations to the market which had the effect of artificially
inflating the market price. The class period includes purchasers of Class
A and Class B Common Stock, as well as 7% cumulative convertible Preferred
Stock (Symbol: KVPHP) and is from February 15, 2008 through November 12,
2008.
Plaintiff seeks to recover damages on behalf of the Class. If you are a
member of the Class as described above, you may move the Court no later
than Monday, February 2, 2009, to serve as a lead plaintiff for the Class.
However, in order to do so, you must meet certain legal requirements
pursuant to the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, participate in this or any other
lawsuit, or have any questions or concerns regarding this notice, or
preservation of your rights, please contact:
William B. Federman
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to: wfederman@aol.com
www.federmanlaw.com
